Now on ScienceBlogs: Oxytocin: Starting with the basics

Seed Media Group

Genetic Future

Commentary on human genetics and evolution, direct-to-consumer genetic testing, and the personal genomics industry.

Search

Profile

Daniel MacArthur
I write about the genetic and evolutionary basis of human variation, and the companies trying to sell you information about your genome.

Subscribe via RSS.
Follow me on Twitter.

Recent Posts

Recent Comments

Archives

Blogs I read:

Consumer Genomics:

Genomic Science:

Genetics/Evolution Blogs:

General Science:

Corporate Blogs:

Skeptics:

personal genomics:

23andMe presents novel genetic associations at American Society of Human Genetics meeting

Category: ashg2009

Personal genomics company 23andMe presented today at the American Society of Human Genetics meeting on novel genetic associations generated by the company using data from their customer base. The presentation showed that the company is capable of doing solid science, although it also raised worrying questions about the validity of survey results from customers who've already seen their genetic data.

Read on »

23andMe performs genome-wide association study on NFL players, fails to find athlete genes

Category: personal genomics

Details are pretty sketchy, but a press release announced today suggests that personal genomics company 23andMe has performed a genome-wide association study comparing 100 current or former professional NFL players with a set of controls of unspecified sample size.The...

Read on »

Scientists call for changes to personal genomics based on comparison of test results

Category: commercial genetic testing

An opinion piece in Nature by scientists including J. Craig Venter calls for changes to the approaches personal genomics companies use to select risk prediction markers and display information to customers.

Read on »

23andMe to offer discounted genome scans to clinicians to boost genomic literacy

Category: direct-to-consumer genetic testing

Personal genomics company 23andMe is considering offering discounted genome scans to clinicians to help them to make sense of the complexities of modern common disease genetics.

Read on »

Guest post: what happens when a personal genomics company goes bankrupt (part 2)

Category: commercial genetic testing

In part 2 of a three-part series of guest post, lawyers Daniel Vorhaus and Lawrence Moore analyse the legal repercussions of a personal genomics company going bankrupt - what will happen to your data?

Read on »

Guest post by Daniel Vorhaus and Lawrence Moore: what happens when a personal genomics company goes bankrupt?

Category: direct-to-consumer genetic testing

In the first of three guest posts, lawyers Daniel Vorhaus and Lawrence Moore explore the intriguing question of what happens to customers' genetic data when a personal genomics company goes bankrupt.

Read on »

New York Times adopts medical establishment line on personal genomics

Category: direct-to-consumer genetic testing

The New York Times has an article pushing the possible dangers of customers peering into their own genome without supervision - but what supervision should customers look for, given that most doctors know less about modern genetics than the customers themselves?

Read on »

Illumina delivers its first commercial personal genome sequence

Category: next-generation sequencing

Sequencing company Illumina has delivered its first commercial personal whole genome sequence to entrepreneur Hermann Hauser.

Read on »

Personal utility vs clinical utility

Category: personal utility

Dan Vorhaus has a great post in Genomics Law Report outlining recommendations made by a recent NIH-CDC workshop on the scientific foundations of personal genomics. The workshop included key stake-holders from academia, policy advisory groups and the personal genomics...

Read on »

Making sense of changing risk predictions from personal genomics

Category: personal genomics

The Public Health Genomics Foundation's Caroline Wright reviews a recent paper exploring the changes personal genomics customers are likely to experience in their risk predictions as genetic research advances.

Read on »

ScienceBlogs

Search ScienceBlogs:

Go to:

Advertisement
Follow ScienceBlogs on Twitter
Visit the Collective Imagination blog
Advertisement
Enter to win

© 2006-2009 Seed Media Group LLC. ScienceBlogs is a registered trademark of Seed Media Group. All rights reserved.

Sites by Seed Media Group: Seed Media Group | ScienceBlogs | SEEDMAGAZINE.COM